StockData
Skye Bioscience, Inc. logo

Skye Bioscience, Inc. (SKYE) stock

SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$1.00−0.06 (-6.10%)

Close on Nov 17, 2026Market cap $35.42MP/E –Yield –

Skye Bioscience market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Skye Bioscience's market cap was $32.30M on Nov 11, 2026, against $324.77M a year earlier. Over the last 5 years it ranged from $32.30M to $2.61B, with a median of $198.06M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$32.30M-82.6%
2025Dec 31, 2025$185.86M-72.9%
2024Dec 31, 2024$686.86M+155.8%
2023Dec 29, 2023$268.49M+323.0%
2022Dec 30, 2022$63.48M-68.0%
2021Dec 31, 2021$198.06M+147.5%
2020Dec 31, 2020$80.02M-43.1%
2019Dec 31, 2019$140.53M-67.1%
2018Dec 31, 2018$427.02M+1045.0%
2017Dec 29, 2017$37.30M-22.5%
2016Dec 30, 2016$48.11M-52.5%
2015Dec 31, 2015$101.24M–

More Skye Bioscience figures

See a number that looks wrong?